Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Remedy Informatics Selected as Registry Solution by the European Group for Blood and Marrow Transplantation (EBMT)

This image opens in the lightbox

News provided by

Remedy Informatics, Inc.

08 Jan, 2013, 08:00 GMT

Share this article

Share toX

Share this article

Share toX

SALT LAKE CITY, Jan. 8, 2013 /PRNewswire/ -- Remedy Informatics, Inc., the leading provider of registries for blood and marrow transplantation centres around the world, announced that the European Group for Blood and Marrow Transplantation (EBMT) has selected Remedy's Mosaic™ Platform as the technology solution for EBMT's Registry Upgrade Project.

(Logo:  http://photos.prnewswire.com/prnh/20120206/SF47874LOGO)

EBMT is upgrading its current EBMT Registry to meet the evolving data management and analysis needs of its member centres, national registries and other partners to facilitate increased collaboration among researchers focused on EBMT's mission to improve patient care and clinical practice in haematopoietic stem cell transplantation.

"Our registry has been an important tool for BMT researchers throughout Europe for decades, and we have recognized the need to upgrade our registry to better meet the evolving needs of our member centres, scientists and collaborating institutions," said Professor Alejandro Madrigal, president of the EBMT. "In our search for new registry technology for our upgrade initiative, we were very impressed with the flexibility and ease of use of Remedy's registry software. Having a registry that incorporates reporting interfaces, user-friendly data visualisation and analytical tools will enable us to deliver substantial benefits to our member BMT researchers and clinicians looking to improve patient outcomes."

Remedy's registries are built on its flagship Mosaic Platform, which offers the industry's most advanced clinical informatics solution. The Mosaic Platform offers highly configurable, user-friendly registries that evolve as a BMT centre's research needs change over time, without the need to engage IT departments or outside technology consultants. The Mosaic Platform will enable the EBMT Registry to broaden its impact on quality patient outcomes as it allows clinical researchers to gain a 360-degree view of the data collected from more than 500 participating BMT centres throughout the world. Researchers and physicians will then be able to analyse the data using powerful pattern recognition and data visualisation tools to further their efforts to improve the quality of care.

"We are thrilled to be selected to partner with EBMT as they work to improve patient outcomes of haematopoietic stem cell transplants (HSCT) throughout Europe and their member countries," said Gary Kennedy, founder and CEO of Remedy Informatics. "The EBMT Registry has been a valuable resource for BMT researchers for more than four decades and we are confident that the power and versatility of our registry software will aid EBMT as they work to expand further the size and value of their HSCT database. Ultimately, the entire European BMT community will benefit as EBMT member centres, collaborators and outside groups use our software to tangibly, measurably, and permanently improve the effectiveness of their care and patient-centred research."

The EBMT Registry is a collection of data from patients undergoing haematopoietic stem cell transplants used in the treatment of leukemia, lymphomas, genetics diseases, etc. and has collected data since the early 1970s. It is the single largest data source of its kind in Europe. The Registry holds more than 400,000 transplant registrations, from roughly 50 countries around the world. The main function of the EBMT Registry is to serve as a source of data for clinical research aimed at improving patient outcomes. Established in 1974, the EBMT is a non-profit organisation that is committed to serving scientists and physicians involved in clinical bone marrow transplantation and aid them in sharing their experiences and developing cooperative studies.

With its ComprehensiveBMT™ registry product, Remedy has established itself as the leader in BMT research informatics. Leading BMT research institutions have selected ComprehensiveBMT to help them expand their efforts to improve BMT discoveries and patient outcomes, including the Princess Margaret Hospital in Toronto, Canada, the University of Utah's Huntsman Cancer Institute, Mercy Healthcare's Jewish Hospital in Cincinnati, Ohio, and the University of Iowa Hospitals and Clinics.  ComprehensiveBMT enables BMT centres to aggregate, map and harmonise BMT data from EHRs, existing databases and other clinical information systems and analyse their data with powerful pattern recognition tools. ComprehensiveBMT also includes user-friendly tools for reporting data to the CIBMTR AGNIS database, producing dashboards and reports on patient outcomes, and facilitating FACT accreditation.

About Remedy Informatics, Inc.

Founded in 2003, Remedy Informatics, Inc. is the leading provider of registry-based informatics software products for Life Science Research and Healthcare Delivery. With a range of oncology, cardiovascular, and other informatics products, Remedy also serves a wide range of leading life science, translational research and healthcare institutions around the world, including the Cleveland Clinic, Massachusetts General Hospital, UC Davis Health Care System, Baylor Health Care System and many more.  Built on the innovative Mosaic™ Platform, all of Remedy's products are configurable and user-friendly. Remedy's mission is to tangibly, measurably and permanently improve Life Science Research and Healthcare Delivery around the world. For more information visit: www.remedyinformatics.com.

Media Contacts

Kristofer Beldin, Remedy Informatics, +1-801-870-9407 (cell) /+1-801-733-3335 (office), kris.beldin@remedyinformatics.com

  

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.